双能CT评估肾脏肿块的诊断效能:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE、Cochrane、Embase和Web of Science(2018年3月),纳入13项研究共969例患者、1193个肾脏肿块。双能CT虚拟单能成像(VMI)的汇总敏感度87%、特异度93%;碘定量技术汇总敏感度99%、特异度91%,其AUC与传统衰减测量无显著差异(p=0.79)。作者认为碘定量技术可在无专用肾脏肿块方案时用于偶发肾脏肿块的定性。
要点
- 双能CT碘定量技术诊断肾脏肿块的汇总敏感度99%、特异度91%,AUC与传统衰减测量无显著差异(p=0.79)。
- 双能CT虚拟单能成像(VMI)汇总敏感度87%、特异度93%,敏感度异质性高(I²=92.0%)。
- 作者认为无专用肾脏肿块CT方案时,碘定量技术可用于偶发肾脏肿块的定性。
核心结论
- 双能CT对肾脏肿块评估具有高准确度。
- 碘定量技术的诊断准确度与传统肾脏肿块CT方案的衰减测量相似。
- 当无专用肾脏肿块方案时,碘定量技术可能用于偶发肾脏肿块的定性。
研究设计与样本
- 系统评价与Meta分析,遵循PRISMA方法,于2018年3月检索MEDLINE、Cochrane系统评价数据库、Embase和Web of Science。
- 共纳入13项研究,969例患者,1193个肾脏肿块。
- 采用QUADAS-2条目评估纳入研究的方法学质量与潜在偏倚。
- 合并计算双能CT虚拟单能成像(VMI)和碘定量技术以及传统衰减测量的敏感度、特异度和诊断比值比,用I²评估异质性。
诊断标准与关键数值
- VMI的汇总敏感度87%(95%CI 80-92%;I²=92.0%)、特异度93%(95%CI 90-96%;I²=18.0%)、汇总诊断比值比183.4(95%CI 30.7-1093.4;I²=61.6%)。
- 碘定量技术的汇总敏感度99%(95%CI 97-100%;I²=17.6%)、特异度91%(95%CI 89-94%;I²=84.2%)、汇总诊断比值比511.5(95%CI 217-1201;I²=0%)。
- 碘定量技术与传统衰减测量的AUC比较无显著差异(p=0.79)。
临床应用与阅片要点
- 作者认为,当无专用肾脏肿块CT方案时,碘定量技术可用于偶发肾脏肿块的定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to perform a systematic review and meta-analysis to evaluate the diagnostic accuracy of dual-energy CT (DECT) for renal mass evaluation. MATERIALS AND METHODS. In March 2018, we searched MEDLINE, Cochrane Database of Systematic Reviews, Embase, and Web of Science databases. Analytic methods were based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Pooled estimates for sensitivity, specificity, and diagnostic odds ratios were calculated for DECT-based virtual monochromatic imaging (VMI) and iodine quantification techniques as well as for conventional attenuation measurements from renal mass CT protocols. I2 was used to evaluate heterogeneity. The methodologic quality of the included studies and potential bias were assessed using items from the Quality Assessment Tool for Diagnostic Accuracy Studies 2 (QUADAS-2). RESULTS. Of the 1043 articles initially identified, 13 were selected for inclusion (969 patients, 1193 renal masses). Cumulative data of sensitivity, specificity, and summary diagnostic odds ratio for VMI were 87% (95% CI, 80-92%; I2, 92.0%), 93% (95% CI, 90-96%; I2, 18.0%), and 183.4 (95% CI, 30.7-1093.4; I2, 61.6%), respectively. Cumulative data of sensitivity, specificity, and summary diagnostic odds ratio for iodine quantification were 99% (95% CI, 97-100%; I2, 17.6%), 91% (95% CI, 89-94%; I2, 84.2%), and 511.5 (95% CI, 217-1201; I2, 0%). No significant differences in AUCs were found when comparing iodine quantification to conventional attenuation measurements (p = 0.79). CONCLUSION. DECT yields high accuracy for renal mass evaluation. Determination of iodine content with the iodine quantification technique shows diagnostic accuracy similar to conventional attenuation measurements from renal mass CT protocols. The iodine quantification technique may be used to characterize incidental renal masses when a dedicated renal mass protocol is not available.
引用
- Bellini D, Panvini N, Laghi A, et al. Systematic Review and Meta-Analysis Investigating the Diagnostic Yield of Dual-Energy CT for Renal Mass Assessment. AJR Am J Roentgenol. 2019. PMID: 30835518. doi:10.2214/AJR.18.20625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。